Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Conditions
Prostate Cancer, Erectile DysfunctionSummary
The purpose of this study is to test two different ways to help men with sexual rehabilitation.
Locations
1 location Found with status Recruiting
Status
- RECRUITING
Contact Person
- Christian Nelson, PhD
- 646-888-0030
Principal Investigator
- Chris Nelson, PhD
Eligibility Criteria
Inclusion Criteria:
* As per medical record, early stage prostate cancer (Pathologic Stage 1/2 with Gleason score =8; or Pathologic Stage 3 with Gleason score =/< 7)
* As per medical record, radical prostatectomy (RP) conducted either at MSKCC or at another institution
* As per medical record, ≤ 9 months post-RP
* As per medical record, moderate erectile functioning pre-surgery (i.e., 15 or greater on the IIEF Erectile Function Domain (EFD) score, or graded their erections as a 1 or 2 on the standard 5 point Urology Erectile Function scale, or have a score of 6 or greater on the 1-10 pre-surgery erectile function scale on the SMRP assessment or have a total score of 15 or greater on items 2-7 on the Prostrate Quality of Life Survey: Sexual Domain)
* As per self report or as per medical record starting penile injections as part of the erectile rehabilitation program at MSKCC
* In the judgment of the consenting professional able to communicate, comprehend, and complete questionnaires in English
Exclusion Criteria:
* Both cavernous nerves fully resected as per surgery report (nerve sparing score of 8 in MSKCC surgeon note), or documented in the progress note that the nerves were fully resected.
* Currently on or has a history of being an Androgen Deprivation Therapy (ADT)
* Has any indication of Prostate-Specific Antigen (PSA)
* As per self report, specific injection phobia
* In the judgment of the consenting professional is unable to provide informed consent and complete study sessions and assessment.
* As per self report or as documented in the medical record, current untreated (e.g. no medication no therapy) major psychiatric disorder (schizophrenia, major depression). Patients diagnosed with a major psychiatric disorder will be reviewed by the study PI to determine eligibility prior to consent.
Study Plan
Standard care plus the ACT intervention (ACT-ED)
EXPERIMENTAL
SC + ACT-ED-Group A uses Acceptance and Commitment Therapy (ACT). In this group, men focus on: long-term goals of rehabilitation; acceptance of the frustration related to ED; identifying and overcoming barriers; and committing to an erectile rehabilitation program. All participants will be asked to complete a set of questionnaires (baseline). The participants can complete it using your personal computer, one of MSKCC computers, in-person or over the phone. The questionnaires will take about 45-60 minutes to complete. You will also complete the same set of questionnaires at 6, 12, 18, and 24 months following study entry. In both groups, the participant will receive three in-person sessions or phone (30-45 minutes), six brief telephone sessions (5-10 minutes), and six monthly phone calls (5-10 minutes)
BEHAVIORAL:
questionnairesBEHAVIORAL:
three in-person sessionsBEHAVIORAL:
monthly phone callsBEHAVIORAL:
Acceptance and Commitment Therapy for Erectile Dysfunction (ACT-ED)
SC plus nurse Enhanced Monitoring and Education (EME)
EXPERIMENTAL
SC + EME-Group B uses enhanced monitoring and education. This group focuses on answering questions about the rehabilitation program, manage technical issues related to injections, and the dose titration of injection medication. Participants in this group will also receive education on the side effects and impact of prostate cancer surgery, and strategies for restarting sexual activity. All participants will be asked to complete a set of questionnaires (baseline). You can complete it using your personal computer, one of MSKCC computers, in-person or over the phone. The questionnaires will take about 45-60 minutes to complete. The participant will also complete the same set of questionnaires at 6, 12, 18, and 24 months following study entry. In both groups, the participant will receive three in-person sessions or phone (30-45 minutes), six brief telephone sessions (5-10 minutes), and six monthly phone calls (5-10 minutes).
BEHAVIORAL:
questionnairesBEHAVIORAL:
three in-person sessionsBEHAVIORAL:
monthly phone callsBEHAVIORAL:
Enhanced Monitoring and Education (EME)
Outcome Measures
Primary Outcome Measures
percentages of patients having an Erectile Function Domain (EFD) total score >= 24
Timeline
Last Updated
July 30, 2024Start Date
March 11, 2016Today
February 5, 2025Completion Date ( Estimated )
December 1, 2025
Sponsors of this trial
Lead Sponsor
Memorial Sloan Kettering Cancer CenterCollaborating Sponsors
Center for Marital and Sexual Health of South Florida